Supernus Pharmaceuticals Inc to Acquire the CNS portfolio of Us WorldMeds LLC - Conference Call Transcript

Apr 29, 2020 / 12:30PM GMT
Operator

Good morning, ladies and gentlemen, and welcome to the Supernus Pharmaceuticals Conference Call.

(Operator Instructions)

As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. You may begin.

Peter Vozzo - Westwicke Partners, LLC - MD

Thank you, Chris. Good morning, everyone, and thank you for joining us today for Supernus Pharmaceuticals conference call to discuss the acquisition of the CNS products of US WorldMeds, which was announced last night. On the call with me today are Supernus' Chief Executive Officer, Jack Khattar; Chief Financial Officer, Greg Patrick; and Vice President, Corporate Development, Bryan Roecklein. Today's call and associated slides are being made available via the Investor Relations section of the company's website at ir.supernus.com.

Following remarks by management, we will open the call to questions. During the course of this call, management may make certain forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot